Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact nam ...

Oscar Health Inc. (NYSE:OSCR) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Mario Schlosser - Co-Founder and CEO Cornelia Miller - VP-Corporate Development and IR Scott Blackley - CFO Conference Call Participants Ricky Goldwasser - Morgan Stanley Stephen Baxter - Wells Fargo Jonathan Yong - Credit Suisse Gary Taylor - Cowen Joshua Raskin - Nephron Research Nathan Rich - Goldman Sachs Operator Good afternoon. My name is Christian and I will be your conference operator for toda ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name of ...

Oscar Health, Inc. Fourth Quarter and Full Year 2021 Earnings Presentation February 10, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direc ...

Oscar Health Inc. (NYSE:OSCR) Q4 2021 Earnings Conference Call February 10, 2022 5:00 PM ET Company Participants Mario Schlosser – Co-Founder and Chief Executive Officer Cornelia Miller – Vice President-Corporate Development and Investor Relations Scott Blackley – Chief Financial Officer Conference Call Participants Marianne Scott – Scott Health Consulting Ricky Goldwasser – Morgan Stanley Adam Ronn – Bank of America Stephen Baxter – Wells Fargo Jonathan Yong – Credit Suisse Josh Raskin – Nephron Nathan Ric ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact ...

Oscar Health, Inc. Third Quarter 2021 Earnings Presentation November 10, 2021 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct policy premiu ...

Oscar Health, Inc. (NYSE:OSCR) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Cornelia Miller – Vice President-Corporate Development and Investor Relations Mario Schlosser – Co-Founder and Chief Executive Officer Scott Blackley – Chief Financial Officer Conference Call Participants Kevin Fischbeck – Bank of America Gary Taylor – Cowen Jonathan Yong – Credit Suisse Michael Ha – Morgan Stanley Stephen Baxter – Wells Fargo Josh Raskin – Nephron Operator Good afternoon. My na ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name ...

Oscar Health, Inc. (NYSE:OSCR) Q2 2021 Earnings Conference Call August 12, 2021 5:00 PM ET Company Participants Cornelia Miller - Vice President of Corporate Development & Investor Relations Mario Schlosser - Co-Founder & Chief Executive Officer Scott Blackley - Chief Financial Officer Conference Call Participants Ricky Goldwasser - Morgan Stanley Stephen Baxter - Wells Fargo Kevin Fischbeck - Bank of America Jailendra Singh - Credit Suisse Josh Raskin - Nephron Operator Good afternoon. My name is Joanna, a ...